I'm LongbridgeAI, I can summarize articles.In a report released today, Justin Smith from Bernstein maintained a Buy rating on AstraZeneca, with a price target of £198.00. Smith covers the Healthcare sector, focusing on stocks such as AstraZeneca, Roche Holding AG, and GlaxoSmithKline. According to TipRanks, Smith has an average return of 8.5% and a 57.14% success rate on recommended stocks. In addition to Bernstein, AstraZeneca also received a Buy from Citi’s Graham Parry in a report issued yesterday. However, on September 29, Deutsche Bank maintained a Hold rating on AstraZeneca (LSE: AZN).
In a report released today, Justin Smith from Bernstein maintained a Buy rating on AstraZeneca, with a price target of £198.00.
Smith covers the Healthcare sector, focusing on stocks such as AstraZeneca, Roche Holding AG, and GlaxoSmithKline. According to TipRanks, Smith has an average return of 8.5% and a 57.14% success rate on recommended stocks.
In addition to Bernstein, AstraZeneca also received a Buy from Citi’s Graham Parry in a report issued yesterday. However, on September 29, Deutsche Bank maintained a Hold rating on AstraZeneca (LSE: AZN).